[TCT2007]2007年TCT会议鼓励对外科医生进行交叉训练

Course to Introduce PCI to Surgeons Debuts at TCT ‘07

　　2007年TCT会议首次开设“Percutaneous Intervention for the Surgeon”教程，将心血管介入治疗技术和方法介绍给心胸外科医生。该教程主要宗旨是把心血管介入治疗基础知识和进展介绍给外科医生，包括介入技术治疗瓣膜病和腔内动脉瘤修复术等。该项目负责人哥伦比亚大学医学院Matthew Williams教授指出：“过去人们更重视心脏介入科和心胸外科的区别，而实际我们的目的是一致的，都在为治疗同样的疾病而努力，只是采用不同技术。心胸外科医生和心内科介入治疗医生应彼此充分了解，相互合作，以便选择最佳治疗策略和技术使患者最大程度获益。”

　　经皮瓣膜修复和置换技术是介入心脏病学又一主要发展方向。外科医生在瓣膜病治疗方面积累了丰富的经验，他们的参与将进一步促进该技术迅速、健康发展。该教程促进了心胸外科与心脏介入医生的交流、培训与合作。

　　（哈尔滨医科大学附属第一医院　李悦 盛力 编译   李为民审校　）

　　（医心网为独家授权网站，转载请注明出自医心网）

Course to Introduce PCI to Surgeons Debuts at TCT ‘07

Cross-training of surgeons will encourage unbiased decision-making.

Cardiothoracic surgeons were introduced to interventional transcatheter techniques and skills during a weekend program held for the first time at the 2007 TCT an¬nual meeting.

The course, “Percutaneous Interven¬tion for the Surgeon,” which took place Saturday and Sunday, offered information ranging from the basics of endovas¬cular intervention to training in some of the advanced techniques practiced by interventional cardiologists, including transcatheter treatment of valve disease and endovascular aneurysm repair.

According to course director Mat¬thew Williams, MD, of the Columbia University School of Medicine, the need for collaboration between surgeons and interventional cardiologists is critical.

“We both work on the same dis¬ease, we just have a different skill set,” said Williams. “Our efforts are better spent treating heart disease than fo¬cusing on departmental barriers.”

Williams holds two appointments at Columbia, both as a surgeon and as an interventional cardiologist. Wil¬liams completed his internship in car¬diothoracic surgery at the University of California in Los Angeles and Co¬lumbia University. Following his sur¬gical internship, Williams accepted a fellowship in interventional cardiol¬ogy at Columbia.

Benefits of cross-training

The course was held primarily to introduce surgeons to the techniques and skills interventional cardiologists practice in the catheterization lab as well as to acknowledge similarities be¬tween the two specialties.

“It seems that in the past, differences between cardiothoracic surgeons and in¬terventional cardiologists have been em¬phasized,” Williams said. “What we each do is a lot more similar than we realize.”

The initiative driving the course was to shape better decision-making in car¬diac care. If surgeons become aware of the technology and techniques available to them, patients will benefit from unbi¬ased information.

The emerging area of transcatheter valve investigation, in particular, would benefit from the participation of sur¬geons. Transcatheter valve repair and replacement is expected to be the next major development in interventional cardiology. According to Williams, it is appropriate to include surgeons in discussions about this rapidly evolving technology because they are already well-versed in the surgical risks to pa¬tients and are experienced in selecting appropriate surgical candidates.

New Society

“Percutaneous Intervention for the Surgeon” included a panel discussion moderated by Williams on enhancing collaboration between cardiothoracic surgeons and interventional cardiolo¬gists. The session also featured the first meeting of the Society of Surgery and Cardiovascular Intervention, which was founded with the goal of furthering cross-training opportunities. Accord¬ing to Williams, the Society will devel¬op means of communication between surgeons and interventionalists, foster collaboration, and teach new skills to both surgeons and interventionalists.